
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
Authors' Affiliations: Departments of 1 Immunology, 2 Pneumology, 3 Cytology, 4 Pathology, University Hospital Center, Saint Etienne, France and 5 Department of Pneumology, University Hospital Center, Lyon, France
Requests for reprints: Christian Genin, Department of Immunology, Bellevue University Hospital Center, University of Saint Etienne, Bd Pasteur, Pavillon 5 Bis, 42055 Saint Etienne, France. Phone: 33-4-77-82-83-79; Fax: 33-4-77-82-84-93; E-mail: Christian.Genin{at}univ-st-etienne.fr.
Purpose: Our main goal was to evaluate a panel of molecular markers for the detection of cancer cells in serous effusions and to determine their value as an adjunctive reverse transcription-PCR (RT-PCR) test to cytologic examination.
Experimental Design: One hundred fourteen serous effusions from 71 patients with tumors and 43 patients with benign diseases were subjected to RT-PCR for expression of carcinoembryonic antigen (CEA), epithelial cell adhesion molecule (Ep-CAM), E-cadherin, mammaglobin, mucin 1 (MUC1) isoforms MUC1/REP, MUC1/Y, and MUC1/Z, calretinin, and Wilms' tumor 1 susceptibility gene.
Results: CEA, Ep-CAM, E-cadherin, and mammaglobin were specifically expressed in malignant effusions. The sensitivity of RT-PCR in cytologically negative malignant effusions was 63.1% combining CEA and Ep-CAM (with 100% specificity) and reached 78.9% adding MUC1/Y or MUC1/Z (with 93% specificity). In the whole population of effusions, the combination of cytology with RT-PCR of CEA and Ep-CAM yielded a 90.1% sensitivity, a specificity and a positive predictive value of 100%, and a 86% negative predictive value for malignancy. Adding MUC1/Y or MUC1/Z to the panel, the sensitivity was 94.5% with 93% specificity, 95.7% PPV, and 90.9% negative predictive value. Moreover, CEA and mammaglobin were specifically expressed in epithelial malignancies, and mammaglobin was mainly expressed in effusions from breast carcinoma (97.3% of specificity).
Conclusions: A combination of cytology and RT-PCR analysis of CEA and Ep-CAM significantly improved the detection sensitivity of tumor cells in serous effusions. RT-PCR analysis of CEA, Ep-CAM, and mammaglobin in serous effusions could be a beneficial adjunct to cytology for the diagnosis of malignancy.
This article has been cited by other articles:
![]() |
H. C. Workman, C. Sweeney, and K. L. Carraway III The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms Cancer Res., April 1, 2009; 69(7): 2845 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Elia, R. Massoud, G. Guggino, B. Cristino, C. Cortese, A. R. De Massimi, and R. Zenobi Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 723 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
F C Schmitt, A Longatto-Filho, A Valent, and P Vielh Molecular techniques in cytopathology practice J. Clin. Pathol., March 1, 2008; 61(3): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hube, Y. Myal, E. Leygue, J. Rollin, Y. Gruel, Y. Yatabe, and on behalf of the authors Expression of Two Breast-Specific Molecules in the Lung J. Mol. Diagn., July 1, 2006; 8(3): 390 - 393. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |